Advertisement

Topics

Latest Biological Therapy NewsRSS

01:41 EDT 19th August 2017 | BioPortfolio

Novavax Inc NVAX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27072017] Prices from USD $250

SummaryNovavax Inc Novavax is a clinicalstage biotechnology company that focuses on the discovery, development and commercialization of vaccines to prevent a range of infectious diseases. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants. The company develops vaccines using its proprietary recombinant nanoparticle vaccine technology including viruslike particle techno...

Stellar Biotechnologies Inc SBOT Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryStellar Biotechnologies Inc Stellar Bio, formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immunestimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injectable product to assess immune response. Its products comprise Stellar KLH protein which can be used in va...

Top 5 Vendors in the Veterinary Diagnostics Market from 2017 to 2021: Technavio

Technavio has announced the top five leading vendors in their recent global veterinary diagnostics market report. This research report also lists seven other prominent vendors that are expected to impact the market during the forecast period. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/2017...

Global Vaccines Market Forecast 14 Vaccines Market, Number of People Immunized Doses of Vaccines Administered [Report Updated: 16082017] Prices from USD $2200

Global Vaccines Market to reach US$ 60 Billion by the year 2022. Pediatric vaccines market is having a dominant market share compared to Adult vaccines market. By 2022 Pediatric vaccines market share will be double the size of adult vaccines market share. Worldwide the number of infants immunized by influenza vaccines remain considerably low than that of adults immunized in year 2017. While the nu...

Cell Line Development Services Global Market Forecast to 2025 [Report Updated: 16082017] Prices from USD $3600

Cell lines are one the major tools used in research for studying the normal physiology and biochemistry of cells, the effects of drugs and toxic compounds on the cells, drug screening and development and large scale manufacturing of biological compounds. Cell culture is the process by which cells are grown under controlled conditions derived from microbial or animal cells. Cell lines are subcultur...

Biologics Outsourcing Global Market Forecast to 2025 [Report Updated: 16082017] Prices from USD $7200

The biologics outsourcing global market is expected to grow at double digit CAGR to reach $70.3 billion by 2025. Biologics are therapeutic entities composed of sugars, proteins, or nucleic acids made from natural sources such as human, animal or micro organisms. Biologics can also include live attenuated microorganisms vaccines, allergenic extracts allergy shots, human cells and tissues transplant...

Nonalcoholicsteatohepatitis NASH Pipeline Analysis [Report Updated: 22022017] Prices from USD $3600

Nonalcoholic steatohepataitis NASH Pipeline Analysis gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development Discovery, Preclinical Clinical. The pipeline focuses on novel pharmacologic drugs regenerative medicines covering small molecules, antibodies, stem cell therapies, recombinant p...

Active Pharmaceutical Ingredients API Global Market Forecast To 2022 [Report Updated: 19052016] Prices from USD $4500

Active Pharmaceutical Ingredients APIs are active substances in a drug intended to achieve pharmacological activity which is having direct effect on diagnosis or treatment of disease. APIs are synthesized by chemical synthesis, fermentation, biotechnological methods or enhanced from natural source. API market is mainly driven by the factors such as patent expiration of blockbuster drugs, increased...

Immune Checkpoint Therapeutics Hot Targets Pipeline Analysis [Report Updated: 26042016] Prices from USD $4500

IMMUNE CHECKPOINT THERAPEUTICS HOT TARGETS PIPELINE ANALYSIS gives comprehensive insights on the various Immune Checkpoint modulators being developed for the treatment of various diseases. The report covers all the drugs being developed in various phases Discovery, Preclinical Clinical development. The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombin...

Nuclear Medicine/Radiopharmaceutical Global Market Forecast To 2022 [Report Updated: 24032016] Prices from USD $4500

Way back to the history, over the past 50 years nuclear medicine sector has displayed a strong link between investments in chemistry and development of radionuclide's and radiolabeled compounds. This advancement has majorly impacted the health care practice. In the present scenario nuclear medicine is considered to be one of the diagnostics and therapeutic modality technique for probing, tracking ...

Immunotherapeutics Global Market Forecast To 2021 [Report Updated: 16112015] Prices from USD $4500

Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy. The global immunotherapeutics market is divided based on the segments, application and geography. Based on the segments, the immu...

Type 2 Diabetes T2D Pipeline Analysis [Report Updated: 09062015] Prices from USD $3600

Type 2 Diabetes T2D Pipeline Analysis gives comprehensive insight on the various drugs being developed for the treatment of T2D. The report covers all the drugs being developed in various phases Discovery, Preclinical, Clinical Marketing. The pipeline focuses on novel pharmacologic drugs regenerative medicines covering small molecules, monoclonal antibodies, stem cell therapies, Gene therapies, ...

Chronic Kidney Disease Pipeline Analysis [Report Updated: 07052015] Prices from USD $3600

Chronic Kidney Disease CKD Pipeline Analysis gives comprehensive insight on the various drugs being developed for the treatment of CKD. The report covers all the drugs being developed in various phases Discovery, Preclinical, Clinical Marketing. The pipeline focuses on novel pharmacologic drugs regenerative medicines covering small molecules, monoclonal antibodies, stem cell therapies and RNAbas...

Dengue Infection Impairs Immune Defense Against Zika

A memory B cell response to Zika virus in dengue-infected patients produced antibodies that were poorly neutralizing in vitro and instead enhanced infection.

Chlamydia Infections Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

DelveInsight's, Chlamydia Infections Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Chlamydia Infections. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Chlamydia Infections. This report provides information on the therapeutic development for Chlamydia Infections, de...

Ligand to Receive $2 Million from WuXi Biologics for Licensing Clinical-Stage anti-PD-1 Antibody Discovered Using the OmniAb® Technology

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand” or “the Company”) announces that it will receive a $2 million payment from WuXi Biologics subsequent to their licensing of exclusive rights to the anti-PD-1 antibody GLS-010 to Arcus Biosciences in North America, Europe, Japan and certain other territories. Ligand is also entitled to futu...

Supported Liquid Extraction Microplate for Biological Fluids

Porvair Sciences announces a new easy-to-use 96-well Supported Liquid Extraction (SLE) microplate designed for high recovery extraction of analytes from biological fluids.    Using the Porvair SLE plate high analyte recovery, free of proteins and phospholipids, is routinely obtainable without the need for offline steps such as protein precipitation. Supported Liq...

Global Avian Influenza Vaccines Market Data Survey Report 2025 [Report Updated: 27072017] Prices from USD $1500

SummaryAvian influenza refers to the disease caused by infection with avian bird influenza flu Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.The global Avian Influenza Vaccines ...

Medical Biological Laboratories Co Ltd 4557 Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryMedical Biological Laboratories Co Ltd MBL is a provider of clinical and basic laboratory diagnostics. The company's products comprise research reagents, diagnostic reagents and companion diagnostics. It provides diagnostic reagents for therapeutic areas of allergy, antiphospholipid syndrome, autoimmune skin diseases, connective tissue diseases, liver diseases, rheumatoid arthritis, tumorr...

Anti-Infectives Rx Boston Returns in September to Bring Together Industry Leaders in the Anti-Infective, Antiviral and Antibacterial Therapy Space

Join Rita Colwell (National Science Foundation), Oreola Donini (Soligenix), Roelof Rongen (Matinas), Jeff Wager (EnBiotix), and others at Harvard Medical School in Boston for an interactive, high-level networking event. Boston, MA (PRWEB) August 17, 2017 Industry CEOs, life science leaders, influential academics and investors will come together on September 19, 2017 for Anti-Infectives Rx. This o...

Spotlight to Shine on National Council for Therapeutic Recreation Certification

DMG Productions explores advances in therapeutic recreation. Jupiter, FL (PRWEB) August 17, 2017 The award-winning producers of the Innovations with Ed Begley, Jr. series, proudly announces that it will feature the National Council for Therapeutic Recreation Certification (NCTRC), slated to air nationwide, fourth quarter 2017. Check your local listings for more information. Established in 1981, N...

HER2 Antibodies Market to Reach US$ 21,669.1 Million by 2025; Perjeta and Other Promising Pipeline Drugs Augur well for Future

ALBANY, New York, August 17, 2017 /PRNewswire/ -- A recent market intelligence study by Transparency Market Research (TMR) suggests that the global HER2 antibodies market offers lucrative opportunities as the awareness regarding breast cancer and personalized medicines spreads. Consequently, the competitive landscape of the HER2 antibodies market is already quite intense with the presence of a...

The Lockwood Group Recognized as a 2017 Inc. 5000 Fastest Growing Private Company in America

STAMFORD, Conn., Aug. 17, 2017 /PRNewswire/ -- The Lockwood Group (Lockwood), a medical communications agency, has been recognized by Inc. magazine in their 2017 Inc. 5000 annual ranking of the fastest-growing private companies in America. This prestigious list of the nation's most successful private companies has become the hallmark of entrepreneurial success and the place where future household ...

FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection

SILVER SPRING, Md., Aug. 17, 2017 /PRNewswire-USNewswire/ -- As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to detect recent Zika virus infection. "At the onset of the Zika virus outbreak, when little was known abo...

ViraCyte Awarded $8.99M from the Cancer Prevention and Research Institute of Texas

HOUSTON, Aug. 17, 2017 /PRNewswire/ -- ViraCyte, LLC, a clinical stage biopharmaceutical company developing cellular immunotherapies for severe viral infections, today announced notification of funding approval for a Product Development Research grant totaling $8.99 million by the Cancer Prevention and Research Institute of Texas (CPRIT) Oversight Committee to support the clinical development...

Quick Search
Advertisement
 

review and buy Biological Therapy market research data and corporate reports here